Global E-Prescribing Market
Global E-Prescribing Market

E-Prescribing Comprehensive Study by Type (Stand-Alone Systems, Integrated Systems), Application (Hospital, Office-based physician), Delivery Mode (Web-based, On-premise/licensed, Cloud-based), Component (Software, Hardware, Services) Players and Region - Global Market Outlook to 2024

E-Prescribing Market Segmented into XX Submarkets. | Forecast Years: 2019- 2024 | CAGR: 21.1%  

Jan 2019 Edition 211 Pages 165 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Market Snapshot:
E-prescribing also known as electronic prescribing is a technology framework that permits medical physicians and practitioners to transfer or send prescriptions to a participating pharmacy electronically instead of using handwritten or faxed notes or calling in prescriptions. The E-Prescribing system is used in various applications including patient historical data, data security checks, preparation of complete medication list, and complete information of formulary. The global E-prescribing market is expected to witness considerable growth owing to growing government programs to implement E-prescribing system to improve the quality of healthcare and reduce medication errors.

Market Trend
E-Prescribing is gaining importance in medical record systems and Rising demand for cloud-based solutions

Market Drivers
Government Initiatives and Incentive Programs have led to the demand of E-prescribing system, More focus on minimizing the medication errors and Advanced features of E-prescribing system drive the market growth

Opportunities
Emerging economies in Asia Pacific region such as India, China and Japan

The Players Covered in the Study are:
Cerner Corporation (U.S), Athenahealth, Inc. (U.S), Allscripts (U.S), eClinicalWorks (U.S), DrFirst (U.S), Practice Fusion, Inc. (U.S), Emdeon (U.S), Surescripts (U.S), Henry Schein, Inc. (U.S) and HealthFusion, Inc. (U.S)
Regulatory Framework:
On March 31, 2010, DEA's Interim Final Rule with Request for Comment titled "Electronic Prescriptions for Controlled Substances" was published in the Federal Register. The rule became effective June 1, 2010. and The rule revises DEA regulations to provide practitioners with the option of writing prescriptions for controlled substances electronically. The regulations also permit pharmacies to receive, dispense, and archive these electronic prescriptions. These regulations are an addition to, not a replacement


Report Objectives / Segmentation Covered
By Type
  • Stand-Alone Systems
  • Integrated Systems
By Application
  • Hospital
  • Office-based physician
By Delivery Mode
  • Web-based
  • On-premise/licensed
  • Cloud-based

By Component
  • Software
  • Hardware
  • Services

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Government Initiatives and Incentive Programs have led to the demand of E-prescribing system
      • 3.2.2. More focus on minimizing the medication errors
      • 3.2.3. Advanced features of E-prescribing system drive the market growth
    • 3.3. Market Challenges
      • 3.3.1. Lack of technological awareness among end users
    • 3.4. Market Trends
      • 3.4.1. E-Prescribing is gaining importance in medical record systems
      • 3.4.2. Rising demand for cloud-based solutions
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global E-Prescribing, by Type, Application, Delivery Mode , Component and Region (value) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global E-Prescribing (Value)
      • 5.2.1. Global E-Prescribing by: Type (Value)
        • 5.2.1.1. Stand-Alone Systems
        • 5.2.1.2. Integrated Systems
      • 5.2.2. Global E-Prescribing by: Application (Value)
        • 5.2.2.1. Hospital
        • 5.2.2.2. Office-based physician
      • 5.2.3. Global E-Prescribing by: Component (Value)
        • 5.2.3.1. Software
        • 5.2.3.2. Hardware
        • 5.2.3.3. Services
      • 5.2.4. Global E-Prescribing Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. E-Prescribing: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Cerner Corporation (U.S)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Athenahealth, Inc. (U.S)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Allscripts (U.S)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. EClinicalWorks (U.S)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. DrFirst (U.S)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Practice Fusion, Inc. (U.S)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Emdeon (U.S)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Surescripts (U.S)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Henry Schein, Inc. (U.S)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. HealthFusion, Inc. (U.S)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global E-Prescribing Sale, by Type, Application, Delivery Mode , Component and Region (value) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global E-Prescribing (Value)
      • 7.2.1. Global E-Prescribing by: Type (Value)
        • 7.2.1.1. Stand-Alone Systems
        • 7.2.1.2. Integrated Systems
      • 7.2.2. Global E-Prescribing by: Application (Value)
        • 7.2.2.1. Hospital
        • 7.2.2.2. Office-based physician
      • 7.2.3. Global E-Prescribing by: Component (Value)
        • 7.2.3.1. Software
        • 7.2.3.2. Hardware
        • 7.2.3.3. Services
      • 7.2.4. Global E-Prescribing Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. E-Prescribing: by Type(USD Million)
  • Table 2. E-Prescribing Stand-Alone Systems , by Region USD Million (2013-2018)
  • Table 3. E-Prescribing Integrated Systems , by Region USD Million (2013-2018)
  • Table 4. E-Prescribing: by Application(USD Million)
  • Table 5. E-Prescribing Hospital , by Region USD Million (2013-2018)
  • Table 6. E-Prescribing Office-based physician , by Region USD Million (2013-2018)
  • Table 7. E-Prescribing: by Component(USD Million)
  • Table 8. E-Prescribing Software , by Region USD Million (2013-2018)
  • Table 9. E-Prescribing Hardware , by Region USD Million (2013-2018)
  • Table 10. E-Prescribing Services , by Region USD Million (2013-2018)
  • Table 11. South America E-Prescribing, by Country USD Million (2013-2018)
  • Table 12. South America E-Prescribing, by Type USD Million (2013-2018)
  • Table 13. South America E-Prescribing, by Application USD Million (2013-2018)
  • Table 14. South America E-Prescribing, by Delivery Mode USD Million (2013-2018)
  • Table 15. South America E-Prescribing, by Component USD Million (2013-2018)
  • Table 16. Brazil E-Prescribing, by Type USD Million (2013-2018)
  • Table 17. Brazil E-Prescribing, by Application USD Million (2013-2018)
  • Table 18. Brazil E-Prescribing, by Delivery Mode USD Million (2013-2018)
  • Table 19. Brazil E-Prescribing, by Component USD Million (2013-2018)
  • Table 20. Argentina E-Prescribing, by Type USD Million (2013-2018)
  • Table 21. Argentina E-Prescribing, by Application USD Million (2013-2018)
  • Table 22. Argentina E-Prescribing, by Delivery Mode USD Million (2013-2018)
  • Table 23. Argentina E-Prescribing, by Component USD Million (2013-2018)
  • Table 24. Rest of South America E-Prescribing, by Type USD Million (2013-2018)
  • Table 25. Rest of South America E-Prescribing, by Application USD Million (2013-2018)
  • Table 26. Rest of South America E-Prescribing, by Delivery Mode USD Million (2013-2018)
  • Table 27. Rest of South America E-Prescribing, by Component USD Million (2013-2018)
  • Table 28. Asia Pacific E-Prescribing, by Country USD Million (2013-2018)
  • Table 29. Asia Pacific E-Prescribing, by Type USD Million (2013-2018)
  • Table 30. Asia Pacific E-Prescribing, by Application USD Million (2013-2018)
  • Table 31. Asia Pacific E-Prescribing, by Delivery Mode USD Million (2013-2018)
  • Table 32. Asia Pacific E-Prescribing, by Component USD Million (2013-2018)
  • Table 33. China E-Prescribing, by Type USD Million (2013-2018)
  • Table 34. China E-Prescribing, by Application USD Million (2013-2018)
  • Table 35. China E-Prescribing, by Delivery Mode USD Million (2013-2018)
  • Table 36. China E-Prescribing, by Component USD Million (2013-2018)
  • Table 37. Japan E-Prescribing, by Type USD Million (2013-2018)
  • Table 38. Japan E-Prescribing, by Application USD Million (2013-2018)
  • Table 39. Japan E-Prescribing, by Delivery Mode USD Million (2013-2018)
  • Table 40. Japan E-Prescribing, by Component USD Million (2013-2018)
  • Table 41. India E-Prescribing, by Type USD Million (2013-2018)
  • Table 42. India E-Prescribing, by Application USD Million (2013-2018)
  • Table 43. India E-Prescribing, by Delivery Mode USD Million (2013-2018)
  • Table 44. India E-Prescribing, by Component USD Million (2013-2018)
  • Table 45. South Korea E-Prescribing, by Type USD Million (2013-2018)
  • Table 46. South Korea E-Prescribing, by Application USD Million (2013-2018)
  • Table 47. South Korea E-Prescribing, by Delivery Mode USD Million (2013-2018)
  • Table 48. South Korea E-Prescribing, by Component USD Million (2013-2018)
  • Table 49. Taiwan E-Prescribing, by Type USD Million (2013-2018)
  • Table 50. Taiwan E-Prescribing, by Application USD Million (2013-2018)
  • Table 51. Taiwan E-Prescribing, by Delivery Mode USD Million (2013-2018)
  • Table 52. Taiwan E-Prescribing, by Component USD Million (2013-2018)
  • Table 53. Australia E-Prescribing, by Type USD Million (2013-2018)
  • Table 54. Australia E-Prescribing, by Application USD Million (2013-2018)
  • Table 55. Australia E-Prescribing, by Delivery Mode USD Million (2013-2018)
  • Table 56. Australia E-Prescribing, by Component USD Million (2013-2018)
  • Table 57. Rest of Asia-Pacific E-Prescribing, by Type USD Million (2013-2018)
  • Table 58. Rest of Asia-Pacific E-Prescribing, by Application USD Million (2013-2018)
  • Table 59. Rest of Asia-Pacific E-Prescribing, by Delivery Mode USD Million (2013-2018)
  • Table 60. Rest of Asia-Pacific E-Prescribing, by Component USD Million (2013-2018)
  • Table 61. Europe E-Prescribing, by Country USD Million (2013-2018)
  • Table 62. Europe E-Prescribing, by Type USD Million (2013-2018)
  • Table 63. Europe E-Prescribing, by Application USD Million (2013-2018)
  • Table 64. Europe E-Prescribing, by Delivery Mode USD Million (2013-2018)
  • Table 65. Europe E-Prescribing, by Component USD Million (2013-2018)
  • Table 66. Germany E-Prescribing, by Type USD Million (2013-2018)
  • Table 67. Germany E-Prescribing, by Application USD Million (2013-2018)
  • Table 68. Germany E-Prescribing, by Delivery Mode USD Million (2013-2018)
  • Table 69. Germany E-Prescribing, by Component USD Million (2013-2018)
  • Table 70. France E-Prescribing, by Type USD Million (2013-2018)
  • Table 71. France E-Prescribing, by Application USD Million (2013-2018)
  • Table 72. France E-Prescribing, by Delivery Mode USD Million (2013-2018)
  • Table 73. France E-Prescribing, by Component USD Million (2013-2018)
  • Table 74. Italy E-Prescribing, by Type USD Million (2013-2018)
  • Table 75. Italy E-Prescribing, by Application USD Million (2013-2018)
  • Table 76. Italy E-Prescribing, by Delivery Mode USD Million (2013-2018)
  • Table 77. Italy E-Prescribing, by Component USD Million (2013-2018)
  • Table 78. United Kingdom E-Prescribing, by Type USD Million (2013-2018)
  • Table 79. United Kingdom E-Prescribing, by Application USD Million (2013-2018)
  • Table 80. United Kingdom E-Prescribing, by Delivery Mode USD Million (2013-2018)
  • Table 81. United Kingdom E-Prescribing, by Component USD Million (2013-2018)
  • Table 82. Netherlands E-Prescribing, by Type USD Million (2013-2018)
  • Table 83. Netherlands E-Prescribing, by Application USD Million (2013-2018)
  • Table 84. Netherlands E-Prescribing, by Delivery Mode USD Million (2013-2018)
  • Table 85. Netherlands E-Prescribing, by Component USD Million (2013-2018)
  • Table 86. Rest of Europe E-Prescribing, by Type USD Million (2013-2018)
  • Table 87. Rest of Europe E-Prescribing, by Application USD Million (2013-2018)
  • Table 88. Rest of Europe E-Prescribing, by Delivery Mode USD Million (2013-2018)
  • Table 89. Rest of Europe E-Prescribing, by Component USD Million (2013-2018)
  • Table 90. MEA E-Prescribing, by Country USD Million (2013-2018)
  • Table 91. MEA E-Prescribing, by Type USD Million (2013-2018)
  • Table 92. MEA E-Prescribing, by Application USD Million (2013-2018)
  • Table 93. MEA E-Prescribing, by Delivery Mode USD Million (2013-2018)
  • Table 94. MEA E-Prescribing, by Component USD Million (2013-2018)
  • Table 95. Middle East E-Prescribing, by Type USD Million (2013-2018)
  • Table 96. Middle East E-Prescribing, by Application USD Million (2013-2018)
  • Table 97. Middle East E-Prescribing, by Delivery Mode USD Million (2013-2018)
  • Table 98. Middle East E-Prescribing, by Component USD Million (2013-2018)
  • Table 99. Africa E-Prescribing, by Type USD Million (2013-2018)
  • Table 100. Africa E-Prescribing, by Application USD Million (2013-2018)
  • Table 101. Africa E-Prescribing, by Delivery Mode USD Million (2013-2018)
  • Table 102. Africa E-Prescribing, by Component USD Million (2013-2018)
  • Table 103. North America E-Prescribing, by Country USD Million (2013-2018)
  • Table 104. North America E-Prescribing, by Type USD Million (2013-2018)
  • Table 105. North America E-Prescribing, by Application USD Million (2013-2018)
  • Table 106. North America E-Prescribing, by Delivery Mode USD Million (2013-2018)
  • Table 107. North America E-Prescribing, by Component USD Million (2013-2018)
  • Table 108. United States E-Prescribing, by Type USD Million (2013-2018)
  • Table 109. United States E-Prescribing, by Application USD Million (2013-2018)
  • Table 110. United States E-Prescribing, by Delivery Mode USD Million (2013-2018)
  • Table 111. United States E-Prescribing, by Component USD Million (2013-2018)
  • Table 112. Canada E-Prescribing, by Type USD Million (2013-2018)
  • Table 113. Canada E-Prescribing, by Application USD Million (2013-2018)
  • Table 114. Canada E-Prescribing, by Delivery Mode USD Million (2013-2018)
  • Table 115. Canada E-Prescribing, by Component USD Million (2013-2018)
  • Table 116. Mexico E-Prescribing, by Type USD Million (2013-2018)
  • Table 117. Mexico E-Prescribing, by Application USD Million (2013-2018)
  • Table 118. Mexico E-Prescribing, by Delivery Mode USD Million (2013-2018)
  • Table 119. Mexico E-Prescribing, by Component USD Million (2013-2018)
  • Table 120. Company Basic Information, Sales Area and Its Competitors
  • Table 121. Company Basic Information, Sales Area and Its Competitors
  • Table 122. Company Basic Information, Sales Area and Its Competitors
  • Table 123. Company Basic Information, Sales Area and Its Competitors
  • Table 124. Company Basic Information, Sales Area and Its Competitors
  • Table 125. Company Basic Information, Sales Area and Its Competitors
  • Table 126. Company Basic Information, Sales Area and Its Competitors
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. E-Prescribing: by Type(USD Million)
  • Table 131. E-Prescribing Stand-Alone Systems , by Region USD Million (2019-2024)
  • Table 132. E-Prescribing Integrated Systems , by Region USD Million (2019-2024)
  • Table 133. E-Prescribing: by Application(USD Million)
  • Table 134. E-Prescribing Hospital , by Region USD Million (2019-2024)
  • Table 135. E-Prescribing Office-based physician , by Region USD Million (2019-2024)
  • Table 136. E-Prescribing: by Component(USD Million)
  • Table 137. E-Prescribing Software , by Region USD Million (2019-2024)
  • Table 138. E-Prescribing Hardware , by Region USD Million (2019-2024)
  • Table 139. E-Prescribing Services , by Region USD Million (2019-2024)
  • Table 140. South America E-Prescribing, by Country USD Million (2019-2024)
  • Table 141. South America E-Prescribing, by Type USD Million (2019-2024)
  • Table 142. South America E-Prescribing, by Application USD Million (2019-2024)
  • Table 143. South America E-Prescribing, by Delivery Mode USD Million (2019-2024)
  • Table 144. South America E-Prescribing, by Component USD Million (2019-2024)
  • Table 145. Brazil E-Prescribing, by Type USD Million (2019-2024)
  • Table 146. Brazil E-Prescribing, by Application USD Million (2019-2024)
  • Table 147. Brazil E-Prescribing, by Delivery Mode USD Million (2019-2024)
  • Table 148. Brazil E-Prescribing, by Component USD Million (2019-2024)
  • Table 149. Argentina E-Prescribing, by Type USD Million (2019-2024)
  • Table 150. Argentina E-Prescribing, by Application USD Million (2019-2024)
  • Table 151. Argentina E-Prescribing, by Delivery Mode USD Million (2019-2024)
  • Table 152. Argentina E-Prescribing, by Component USD Million (2019-2024)
  • Table 153. Rest of South America E-Prescribing, by Type USD Million (2019-2024)
  • Table 154. Rest of South America E-Prescribing, by Application USD Million (2019-2024)
  • Table 155. Rest of South America E-Prescribing, by Delivery Mode USD Million (2019-2024)
  • Table 156. Rest of South America E-Prescribing, by Component USD Million (2019-2024)
  • Table 157. Asia Pacific E-Prescribing, by Country USD Million (2019-2024)
  • Table 158. Asia Pacific E-Prescribing, by Type USD Million (2019-2024)
  • Table 159. Asia Pacific E-Prescribing, by Application USD Million (2019-2024)
  • Table 160. Asia Pacific E-Prescribing, by Delivery Mode USD Million (2019-2024)
  • Table 161. Asia Pacific E-Prescribing, by Component USD Million (2019-2024)
  • Table 162. China E-Prescribing, by Type USD Million (2019-2024)
  • Table 163. China E-Prescribing, by Application USD Million (2019-2024)
  • Table 164. China E-Prescribing, by Delivery Mode USD Million (2019-2024)
  • Table 165. China E-Prescribing, by Component USD Million (2019-2024)
  • Table 166. Japan E-Prescribing, by Type USD Million (2019-2024)
  • Table 167. Japan E-Prescribing, by Application USD Million (2019-2024)
  • Table 168. Japan E-Prescribing, by Delivery Mode USD Million (2019-2024)
  • Table 169. Japan E-Prescribing, by Component USD Million (2019-2024)
  • Table 170. India E-Prescribing, by Type USD Million (2019-2024)
  • Table 171. India E-Prescribing, by Application USD Million (2019-2024)
  • Table 172. India E-Prescribing, by Delivery Mode USD Million (2019-2024)
  • Table 173. India E-Prescribing, by Component USD Million (2019-2024)
  • Table 174. South Korea E-Prescribing, by Type USD Million (2019-2024)
  • Table 175. South Korea E-Prescribing, by Application USD Million (2019-2024)
  • Table 176. South Korea E-Prescribing, by Delivery Mode USD Million (2019-2024)
  • Table 177. South Korea E-Prescribing, by Component USD Million (2019-2024)
  • Table 178. Taiwan E-Prescribing, by Type USD Million (2019-2024)
  • Table 179. Taiwan E-Prescribing, by Application USD Million (2019-2024)
  • Table 180. Taiwan E-Prescribing, by Delivery Mode USD Million (2019-2024)
  • Table 181. Taiwan E-Prescribing, by Component USD Million (2019-2024)
  • Table 182. Australia E-Prescribing, by Type USD Million (2019-2024)
  • Table 183. Australia E-Prescribing, by Application USD Million (2019-2024)
  • Table 184. Australia E-Prescribing, by Delivery Mode USD Million (2019-2024)
  • Table 185. Australia E-Prescribing, by Component USD Million (2019-2024)
  • Table 186. Rest of Asia-Pacific E-Prescribing, by Type USD Million (2019-2024)
  • Table 187. Rest of Asia-Pacific E-Prescribing, by Application USD Million (2019-2024)
  • Table 188. Rest of Asia-Pacific E-Prescribing, by Delivery Mode USD Million (2019-2024)
  • Table 189. Rest of Asia-Pacific E-Prescribing, by Component USD Million (2019-2024)
  • Table 190. Europe E-Prescribing, by Country USD Million (2019-2024)
  • Table 191. Europe E-Prescribing, by Type USD Million (2019-2024)
  • Table 192. Europe E-Prescribing, by Application USD Million (2019-2024)
  • Table 193. Europe E-Prescribing, by Delivery Mode USD Million (2019-2024)
  • Table 194. Europe E-Prescribing, by Component USD Million (2019-2024)
  • Table 195. Germany E-Prescribing, by Type USD Million (2019-2024)
  • Table 196. Germany E-Prescribing, by Application USD Million (2019-2024)
  • Table 197. Germany E-Prescribing, by Delivery Mode USD Million (2019-2024)
  • Table 198. Germany E-Prescribing, by Component USD Million (2019-2024)
  • Table 199. France E-Prescribing, by Type USD Million (2019-2024)
  • Table 200. France E-Prescribing, by Application USD Million (2019-2024)
  • Table 201. France E-Prescribing, by Delivery Mode USD Million (2019-2024)
  • Table 202. France E-Prescribing, by Component USD Million (2019-2024)
  • Table 203. Italy E-Prescribing, by Type USD Million (2019-2024)
  • Table 204. Italy E-Prescribing, by Application USD Million (2019-2024)
  • Table 205. Italy E-Prescribing, by Delivery Mode USD Million (2019-2024)
  • Table 206. Italy E-Prescribing, by Component USD Million (2019-2024)
  • Table 207. United Kingdom E-Prescribing, by Type USD Million (2019-2024)
  • Table 208. United Kingdom E-Prescribing, by Application USD Million (2019-2024)
  • Table 209. United Kingdom E-Prescribing, by Delivery Mode USD Million (2019-2024)
  • Table 210. United Kingdom E-Prescribing, by Component USD Million (2019-2024)
  • Table 211. Netherlands E-Prescribing, by Type USD Million (2019-2024)
  • Table 212. Netherlands E-Prescribing, by Application USD Million (2019-2024)
  • Table 213. Netherlands E-Prescribing, by Delivery Mode USD Million (2019-2024)
  • Table 214. Netherlands E-Prescribing, by Component USD Million (2019-2024)
  • Table 215. Rest of Europe E-Prescribing, by Type USD Million (2019-2024)
  • Table 216. Rest of Europe E-Prescribing, by Application USD Million (2019-2024)
  • Table 217. Rest of Europe E-Prescribing, by Delivery Mode USD Million (2019-2024)
  • Table 218. Rest of Europe E-Prescribing, by Component USD Million (2019-2024)
  • Table 219. MEA E-Prescribing, by Country USD Million (2019-2024)
  • Table 220. MEA E-Prescribing, by Type USD Million (2019-2024)
  • Table 221. MEA E-Prescribing, by Application USD Million (2019-2024)
  • Table 222. MEA E-Prescribing, by Delivery Mode USD Million (2019-2024)
  • Table 223. MEA E-Prescribing, by Component USD Million (2019-2024)
  • Table 224. Middle East E-Prescribing, by Type USD Million (2019-2024)
  • Table 225. Middle East E-Prescribing, by Application USD Million (2019-2024)
  • Table 226. Middle East E-Prescribing, by Delivery Mode USD Million (2019-2024)
  • Table 227. Middle East E-Prescribing, by Component USD Million (2019-2024)
  • Table 228. Africa E-Prescribing, by Type USD Million (2019-2024)
  • Table 229. Africa E-Prescribing, by Application USD Million (2019-2024)
  • Table 230. Africa E-Prescribing, by Delivery Mode USD Million (2019-2024)
  • Table 231. Africa E-Prescribing, by Component USD Million (2019-2024)
  • Table 232. North America E-Prescribing, by Country USD Million (2019-2024)
  • Table 233. North America E-Prescribing, by Type USD Million (2019-2024)
  • Table 234. North America E-Prescribing, by Application USD Million (2019-2024)
  • Table 235. North America E-Prescribing, by Delivery Mode USD Million (2019-2024)
  • Table 236. North America E-Prescribing, by Component USD Million (2019-2024)
  • Table 237. United States E-Prescribing, by Type USD Million (2019-2024)
  • Table 238. United States E-Prescribing, by Application USD Million (2019-2024)
  • Table 239. United States E-Prescribing, by Delivery Mode USD Million (2019-2024)
  • Table 240. United States E-Prescribing, by Component USD Million (2019-2024)
  • Table 241. Canada E-Prescribing, by Type USD Million (2019-2024)
  • Table 242. Canada E-Prescribing, by Application USD Million (2019-2024)
  • Table 243. Canada E-Prescribing, by Delivery Mode USD Million (2019-2024)
  • Table 244. Canada E-Prescribing, by Component USD Million (2019-2024)
  • Table 245. Mexico E-Prescribing, by Type USD Million (2019-2024)
  • Table 246. Mexico E-Prescribing, by Application USD Million (2019-2024)
  • Table 247. Mexico E-Prescribing, by Delivery Mode USD Million (2019-2024)
  • Table 248. Mexico E-Prescribing, by Component USD Million (2019-2024)
  • Table 249. Research Programs/Design for This Report
  • Table 250. Key Data Information from Secondary Sources
  • Table 251. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global E-Prescribing: by Type USD Million (2013-2018)
  • Figure 5. Global E-Prescribing: by Application USD Million (2013-2018)
  • Figure 6. Global E-Prescribing: by Component USD Million (2013-2018)
  • Figure 7. South America E-Prescribing Share (%), by Country
  • Figure 8. Asia Pacific E-Prescribing Share (%), by Country
  • Figure 9. Europe E-Prescribing Share (%), by Country
  • Figure 10. MEA E-Prescribing Share (%), by Country
  • Figure 11. North America E-Prescribing Share (%), by Country
  • Figure 12. Global E-Prescribing share by Players 2018 (%)
  • Figure 13. Global E-Prescribing share by Players (Top 3) 2018(%)
  • Figure 14. Global E-Prescribing share by Players (Top 5) 2018(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Cerner Corporation (U.S) Revenue, Net Income and Gross profit
  • Figure 17. Cerner Corporation (U.S) Revenue: by Geography 2018
  • Figure 18. Athenahealth, Inc. (U.S) Revenue, Net Income and Gross profit
  • Figure 19. Athenahealth, Inc. (U.S) Revenue: by Geography 2018
  • Figure 20. Allscripts (U.S) Revenue, Net Income and Gross profit
  • Figure 21. Allscripts (U.S) Revenue: by Geography 2018
  • Figure 22. EClinicalWorks (U.S) Revenue, Net Income and Gross profit
  • Figure 23. EClinicalWorks (U.S) Revenue: by Geography 2018
  • Figure 24. DrFirst (U.S) Revenue, Net Income and Gross profit
  • Figure 25. DrFirst (U.S) Revenue: by Geography 2018
  • Figure 26. Practice Fusion, Inc. (U.S) Revenue, Net Income and Gross profit
  • Figure 27. Practice Fusion, Inc. (U.S) Revenue: by Geography 2018
  • Figure 28. Emdeon (U.S) Revenue, Net Income and Gross profit
  • Figure 29. Emdeon (U.S) Revenue: by Geography 2018
  • Figure 30. Surescripts (U.S) Revenue, Net Income and Gross profit
  • Figure 31. Surescripts (U.S) Revenue: by Geography 2018
  • Figure 32. Henry Schein, Inc. (U.S) Revenue, Net Income and Gross profit
  • Figure 33. Henry Schein, Inc. (U.S) Revenue: by Geography 2018
  • Figure 34. HealthFusion, Inc. (U.S) Revenue, Net Income and Gross profit
  • Figure 35. HealthFusion, Inc. (U.S) Revenue: by Geography 2018
  • Figure 36. Global E-Prescribing: by Type USD Million (2013-2018)
  • Figure 37. Global E-Prescribing: by Application USD Million (2013-2018)
  • Figure 38. Global E-Prescribing: by Component USD Million (2013-2018)
  • Figure 39. South America E-Prescribing Share (%), by Country
  • Figure 40. Asia Pacific E-Prescribing Share (%), by Country
  • Figure 41. Europe E-Prescribing Share (%), by Country
  • Figure 42. MEA E-Prescribing Share (%), by Country
  • Figure 43. North America E-Prescribing Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Cerner Corporation (U.S)
  • Athenahealth, Inc. (U.S)
  • Allscripts (U.S)
  • eClinicalWorks (U.S)
  • DrFirst (U.S)
  • Practice Fusion, Inc. (U.S)
  • Emdeon (U.S)
  • Surescripts (U.S)
  • Henry Schein, Inc. (U.S)
  • HealthFusion, Inc. (U.S)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation